Effectiveness of Covid-19 vaccines (Covishield(TM) and Covaxin (®)) in healthcare workers in Mumbai, India: A retrospective cohort analysis

BACKGROUND: India started its vaccination programme for Coronavirus-19 infection (COVID-19) on 16 January 2021 with Covishield(TM) (Oxford/Astra Zeneca vaccine manufactured by Serum Institute of India) and Covaxin (®) (Bharat Biotech, India). We designed the present study to study the effectiveness...

Descripción completa

Detalles Bibliográficos
Autores principales: Contractor, Aashish, Shivaprakash, Shashikala, Tiwari, Anjali, Setia, Maninder Singh, Gianchandani, Tarang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612509/
https://www.ncbi.nlm.nih.gov/pubmed/36301977
http://dx.doi.org/10.1371/journal.pone.0276759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612509/
https://www.ncbi.nlm.nih.gov/pubmed/36301977
http://dx.doi.org/10.1371/journal.pone.0276759

Ejemplares similares